These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 37093406)

  • 21. PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Wang J; Wang Y; Wu L; Zhang J; Lai W; Wang Z
    J Hematol Oncol; 2016 Sep; 9(1):84. PubMed ID: 27613189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haemophagocytic lymphohistiocytosis and Epstein-Barr virus: a complex relationship with diverse origins, expression and outcomes.
    El-Mallawany NK; Curry CV; Allen CE
    Br J Haematol; 2022 Jan; 196(1):31-44. PubMed ID: 34169507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with severe cardiac complications.
    Kawamura Y; Miura H; Matsumoto Y; Uchida H; Kudo K; Hata T; Ito Y; Kimura H; Yoshikawa T
    BMC Pediatr; 2016 Oct; 16(1):172. PubMed ID: 27793118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical Characteristics and Prognostic Analysis of 59 Adult Patients with Epstein-Barr Virus-Associated Hemophagocytic Syndrome].
    Zhou YL; Li F; Zhang RY; Chen ZW; Zhong N; Tang WP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):657-662. PubMed ID: 32319412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein Virus Barr-Positive Diffuse Large B-Cell Lymphoma Associated with Hemophagocytic Lymphohistiocytosis.
    Ricard JA; Charles R; Tommee CG; Yohe S; Bell WR; Flanagan ME
    J Neuropathol Exp Neurol; 2020 Aug; 79(8):915-920. PubMed ID: 32647871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epstein-Barr virus-related hemophagocytic lymphohistiocytosis complicated with coronary artery dilation and acute renal injury in a boy with a novel X-linked inhibitor of apoptosis protein (XIAP) variant: a case report.
    Chen RY; Li XZ; Lin Q; Zhu Y; Shen YY; Xu QY; Zhu XM; Bai ZJ; Li Y
    BMC Pediatr; 2020 Oct; 20(1):456. PubMed ID: 33008347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis-a dangerous disease.
    Jin Z; Wang Y; Wei N; Wang Z
    Ann Hematol; 2020 Jul; 99(7):1575-1581. PubMed ID: 32500223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults and adolescents-a life-threatening disease: analysis of 133 cases from a single center.
    Lai W; Wang Y; Wang J; Wu L; Jin Z; Wang Z
    Hematology; 2018 Dec; 23(10):810-816. PubMed ID: 29957156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Characteristic and prognosis of patients with non-EBV infection-associated hemophagocytic lymphohistiocytosis].
    You YH; Wang JS; Wang Z
    Zhonghua Xue Ye Xue Za Zhi; 2022 Feb; 43(2):128-133. PubMed ID: 35381673
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical Significance of Plasma Soluble MICB in Children With EBV-associated Hemophagocytic Lymphohistiocytosis.
    Wei A; Zhang L; Ma H; Cui L; Zhang Q; Wang D; Chen S; Du J; Zhao X; Wang T; Zhang R; Zheng H; Li Z
    J Pediatr Hematol Oncol; 2023 May; 45(4):e446-e454. PubMed ID: 36898046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disparity analysis and prognostic value of pretreatment whole blood Epstein-Barr virus DNA load and Epstein-Barr encoding region status in lymphomas: A retrospective multicenter study in Huaihai Lymphoma Working Group.
    Shen Z; Hu L; Yao M; He C; Liu Q; Wang F; Gu W; Wang Y; Dong M; Zhu T; Yin T; Li F; Jin Y; Huang S; Zhang H; Sang W;
    Int J Cancer; 2022 Jan; 150(2):327-334. PubMed ID: 34520566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disparity Analysis of Clinical Features and Prognostic Evaluation of Hemophagocytic Lymphohistiocytosis in Pediatric and Adult Patients: A Retrospective Multicenter Study of 525 Cases in HHLWG.
    Wang X; Zhou Y; Sun Q; Zhou H; Zhang Q; Shen Z; Huang J; Xue Y; Yan D; Fang Y; Sang W
    Acta Haematol; 2023; 146(3):185-195. PubMed ID: 36623498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Children with lymphoma presenting with hemophagocytic lymphohistiocytosis.
    Aksu T; Bayhan T; Gülhan B; Çakmakcı S; Oğuz AS; Yaralı N; Özbek NY; İlhan İ
    Turk J Pediatr; 2020; 62(2):284-288. PubMed ID: 32419422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic active EBV infection associated with NK cell lymphoma and hemophagocytic lymphohistiocytosis in a 27-year-old woman: A case report.
    Wang YD; Wu LL; Ma LY; Shang XB; Li ZY; Wang W; Shen C; Yang JJ; Sun LX; Zhao CY
    Medicine (Baltimore); 2019 Jan; 98(2):e14032. PubMed ID: 30633196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors predicting the recurrence of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children after treatment using the HLH-2004 protocol.
    Yanagaisawa R; Matsuda K; Ohga S; Kanegane H; Morimoto A; Okamoto Y; Ohara A; Fukushima K; Sotomatsu M; Nomura K; Saito AM; Horibe K; Ishii E; Nakazawa Y
    Int J Hematol; 2019 May; 109(5):612-617. PubMed ID: 30788725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical features and outcome analysis of 83 childhood Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-2004 protocol].
    Xiao L; Xian Y; Dai BT; Su YC; Xiao JW; Zheng QC; Zhao XD; Yu J
    Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):668-72. PubMed ID: 22339824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early Use of Blood Purification in Severe Epstein-Barr Virus-Associated Hemophagocytic Syndrome.
    Huang P; Huang C; Xu H; Lu J; Tian R; Wang Z; Chen Y
    Pediatrics; 2020 Jun; 145(6):. PubMed ID: 32430444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T Cell-Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis (HLH) Occurs in Non-Asians and Is Associated with a T Cell Activation State that Is Comparable to Primary HLH.
    Shamriz O; Kumar D; Shim J; Briones M; Quarmyne MO; Chonat S; Lucas L; Edington H; White MH; Mahajan A; Park S; Chandrakasan S
    J Clin Immunol; 2021 Oct; 41(7):1582-1596. PubMed ID: 34173902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphoma-based therapy for refractory or relapsed Epstein-Barr virus-related hemophagocytic lymphohistiocytosis in children.
    Cheng CN; Chu WY; Chang KC; Chen JS
    J Formos Med Assoc; 2022 Nov; 121(11):2351-2355. PubMed ID: 35123848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens.
    Chellapandian D; Das R; Zelley K; Wiener SJ; Zhao H; Teachey DT; Nichols KE;
    Br J Haematol; 2013 Aug; 162(3):376-82. PubMed ID: 23692048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.